ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1794

OA-associated pain sensitivity is reduced in OA-protected MRL/MpJ mice, partially mediated by the gut microbiome, and transferable via microbiome transplantation

Gabriella Dyson1, Montana Barrett1, Nicholas Hanebutt1, Aleksander Szymczak2, Cindy Miranda Brawner1, Pratibha Dube3, Ausitn Lopez1, Padmaja Mehta-d'Souza1 and Matlock Jeffries2, 1Oklahoma Medical Research Foundation, Oklahoma City, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Edmond, OK

Meeting: ACR Convergence 2025

Keywords: Animal Model, microbiome, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: MRL/MpJ (MRL) mice are protected from developing post-traumatic osteoarthritis (OA) histologic changes. We have previously shown the gut microbiome to play a key role in mediating this OA protection, wherein microbiome transplantation from MRL mice to B6 mice can prevent OA. The goal of the present study was to examine the effects of microbiome manipulation on OA-associated pain in MRL and wild-type C57BL/6 (B6) mice.

Methods: Young adult male B6 or MRL mice (11 weeks of age) underwent one-time microbiome transplantation via oral gavage of 200uL of diluted cecal contents from adult reciprocal-strain animals (n=6 MRL-into-B6, n=6 B6-into-MRL), or 200uL control solution (n=6 MRL, n=6 B6). One week later, unilateral destabilization of the medial meniscus (DMM) surgery was used to induce OA. Pain sensitivity thresholds were measured via small animal algometry of the operated and contralateral knees prior to intervention (10 weeks of age). Algometry data were collected every 4 weeks until euthanasia 12 weeks after DMM.

Results: There were no differences at baseline in pain sensitivity, although there was a trend towards lower pain sensitivity in MRL animals at all timepoints (P=0.073 at baseline, P=0.069 at 4 weeks, P=0.033 at 8 weeks, P=0.16 at 12 weeks). At 4 weeks after DMM, MRL-into-B6 transplanted mice had substantially reduced pain sensitivity compared to B6 controls (P=0.0090), which was lost at later timepoints (P=0.17 at 8 weeks, P=0.23 at 12 weeks, Figure 1). B6-into-MRL transplantation did not alter pain sensitivity in MRL recipient mice at any timepoint. In the contralateral (unoperated) knee, we found MRL mice to have reduced pain sensitivity at all timepoints. MRL-into-B6 transplantation reduced pain sensitivity at 4 weeks (P=0.015) and 12 weeks (P=0.032). B6-into-MRL transplantation increased pain sensitivity at 4 weeks (P=0.012). Correlation of gut microbiome changes with pain sensitivity is ongoing.

Conclusion: Knee pain sensitivity is reduced in OA-protected MRL mice compared to wild-type B6 mice and is partially mediated by the gut microbiome, although the effects of a single timepoint microbiome manipulation are lost at timepoints beyond 4 weeks post-DMM. Future studies should investigate whether sustained changes in pain sensitivity could be seen with repeated microbiome manipulation, and whether OA-associated behavioral changes are similarly mitigated with microbiome manipulation.

Supporting image 1Figure 1: Pain sensitivity (withdrawal) thresholds by gut microbiome transplantation group


Disclosures: G. Dyson: None; M. Barrett: None; N. Hanebutt: None; A. Szymczak: None; C. Miranda Brawner: None; P. Dube: None; A. Lopez: None; P. Mehta-d'Souza: None; M. Jeffries: Being Inc., 1.

To cite this abstract in AMA style:

Dyson G, Barrett M, Hanebutt N, Szymczak A, Miranda Brawner C, Dube P, Lopez A, Mehta-d'Souza P, Jeffries M. OA-associated pain sensitivity is reduced in OA-protected MRL/MpJ mice, partially mediated by the gut microbiome, and transferable via microbiome transplantation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/oa-associated-pain-sensitivity-is-reduced-in-oa-protected-mrl-mpj-mice-partially-mediated-by-the-gut-microbiome-and-transferable-via-microbiome-transplantation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oa-associated-pain-sensitivity-is-reduced-in-oa-protected-mrl-mpj-mice-partially-mediated-by-the-gut-microbiome-and-transferable-via-microbiome-transplantation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology